BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Levemir (insulin detemir) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Levemir (insulin detemir)\, from Clinical
 Trials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT01239550-317@assetmemo.bio
DTSTAMP:20261121T004958Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:Levemir (insulin detemir): Phase na readout est. (NCT01239550)
DESCRIPTION:Levemir (insulin detemir)\, phase na.\nStudy: Insulin Detemir i
 n Obesity Management\nEstimated primary completion: December 2028. This is
  a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can
  move.\nDrug page: https://assetmemo.bio/drug/insulin-detemir#upcoming-eve
 nts\nRegistry record: https://clinicaltrials.gov/study/NCT01239550
URL:https://assetmemo.bio/drug/insulin-detemir#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
